世界のヒト組換えDNA市場は、2022年までに3,487億ドル、2027年までに4,969億ドルを超え、2022年から2027年までのCAGRは7.3％になると予想されます。
目次
Chapter- 1: Introduction
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Market Estimates
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Human Recombinant DNA, by Region, Through 2027
Figure 0A : Global Market for Human Recombinant DNA, by Region, 2020-2027
Figure 0B : Global Market Shares of Human Recombinant DNA, by Region, 2021
Chapter- 3: Overview
Homologous Recombination (HR)
Targets for Cancer Therapy
Chapter- 4: Impact of COVID-19 Pandemic
Chapter- 5: Market Dynamics
Market Drivers
Market Restraints
Opportunities
Chapter- 6: Market Breakdown by Product Type
Human Protein Replacements
Therapeutic Agents for Human Diseases
Vaccines
Table 3 : Global Human Recombinant DNA Market, by Product Type, Through 2027
Figure 1 : Global Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 2 : Global Market for Human Recombinant DNA, by Product Type, 2020-2027
Chapter- 7: Market Breakdown by End User
Biotechnology and Pharmaceutical Industry
Research Laboratories and Academic Institutes
Table 8 : Global Market for Human Recombinant DNA, by End User, Through 2027
Figure 7 : Global Market Shares of Human Recombinant DNA, by End User, 2021
Figure 8 : Global Market for Human Recombinant DNA, by End User, 2020-2027
Chapter- 8: Market Breakdown by Region
Global Market by Region
Chapter- 9: Competitive Landscape
Overview
Chapter- 10: Company Profiles
ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
ELI LILLY
MERCK & CO. INC.
SANOFI S.A.
TAKEDA PHARMACEUTICAL CO LTD.
